Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
Authors
Coombes, RKilburn, L
Snowdon, C
Paridaens, R
Coleman, R
Jones, S
Jassem, J
Van de Velde, C
Delozier, T
Alvarez, I
Stewart, Alan L
Affiliation
Intergroup Exemestane StudyIssue Date
2007
Metadata
Show full item recordCitation
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial 2007, 369 (9561):559 The LancetJournal
The LancetDOI
10.1016/S0140-6736(07)60200-1Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0140673607602001Type
ArticleLanguage
enISSN
01406736ae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(07)60200-1